“As we support scientific discoveries that promote better health and wellness throughout our nation, sustained and elevated funding for biomedical and behavioral research is critical, including at the National Institute of Nursing Research. We are grateful to our nurse scientists who are advancing these evidence-based interventions and leading innovative research that addresses chronic disease management and improves patient care.”
Deborah Trautman, PhD, RN, FAAN
President and Chief Executive Officer, American Association of Colleges of Nursing
“Alzheimer’s disease touches millions of families, and every research investment brings us closer to a future where fewer people experience the heartbreak of this devastating disease. That progress is only possible because of sustained investment in the National Institutes of Health, which is helping researchers better understand Alzheimer’s disease, improve early diagnosis, identify opportunities to reduce risk, advance new treatments, and ultimately find a cure. We urge Congress to continue strengthening that commitment so researchers can build on the momentum already changing lives and bring new hope to every family affected by Alzheimer’s.”
Catherine Patterson,Acting Chief Operating Officer, UsAgainstAlzheimer’s
“For decades, federal investment in medical research has transformed cancer care and improved the lives of millions of Americans. Research supported through NIH, NCI, and other federal programs has helped advance radiation therapy into one of the most effective and precise cancer treatments available today, allowing physicians to target tumors more accurately while reducing side effects. At a time of unprecedented scientific opportunity, sustained federal support is needed now more than ever to accelerate innovation in radiation therapy and ensure the next generation of breakthroughs reaches patients in every community. ASTRO urges Congress to build on its longstanding bipartisan commitment to medical research by providing robust, predictable funding for NIH, NCI, ARPA-H, CDC, and other vital research programs. Continued investment today will drive the discoveries, treatments, and cures of tomorrow.”
Sameer R. Keole, MD, FASTROBoard Chair, American Society for Radiation Oncology (ASTRO)
“For patients across every disease community waiting for better treatments and cures, medical research isn’t an abstract investment—it’s a lifeline. Federal investment in the National Institutes of Health makes those breakthroughs possible by supporting the research that leads to new treatments, cures, and longer, healthier lives. The Rally for Medical Research is a reminder that patients cannot afford for progress to stall, and United for Cures is proud to be a champion. Congress must continue its bipartisan commitment to robust, predictable NIH funding so promising discoveries can reach the people who need them most.”
Erika SwardExecutive Director, United for Cures
“We are entering the most promising era in pancreatic cancer research, with progress once thought unimaginable now becoming reality for patients. These breakthroughs did not happen by chance. They are the result of long-term investment in basic science, a strong federal research enterprise, and collaboration across every sector of the biomedical community. The Lustgarten Foundation proudly joins the Rally for Medical Research in urging policymakers to sustain the investment that makes lifesaving discoveries possible.”
Linda TantawiChief Executive Officer, The Lustgarten Foundation
“More than 7 million Americans are living with Alzheimer’s today, and that number continues to climb. But we are in a different moment than we were even a few years ago — new treatments are slowing the disease for those in its early stages, and researchers are making real progress on earlier detection and prevention. This progress exists because Congress, on a bipartisan basis, has continued to invest in the National Institutes of Health and the scientists working to outpace this disease. That support must continue until a world without Alzheimer’s and all other dementia is not a vision, but a reality.”
Rachel Conant
Senior vice president of public policy, Alzheimer’s Association and executive director, Alzheimer’s Impact Movement (AIM)
“The NIH is more than a funding agency—it is the foundation that allows scientists to pursue discoveries about health and disease that improve and save lives. Many of the treatments we use today began as ideas supported by NIH research grants. Scientific progress is rarely instantaneous but rather rests on years of foundational research, in many instances initially unrelated to the diseases they ultimately treat and prevent. NIH represents the national commitment that breakthrough discoveries require, and ensures our global leadership in health research.”
Mike Lehman, PhDPresident, Federation of American Societies for Experimental Biology (FASEB)
“The NIH is more than a funding agency—it is the foundation that allows scientists to pursue discoveries about health and disease that improve and save lives. Many of the treatments we use today began as ideas supported by NIH research grants. Scientific progress is rarely instantaneous but rather rests on years of foundational research, in many instances initially unrelated to the diseases they ultimately treat and prevent. NIH represents the national commitment that breakthrough discoveries require, and ensures our global leadership in health research.”
Mike Lehman, PhDPresident, Federation of American Societies for Experimental Biology (FASEB)